CSF3 and Sepsis: While this meta-analysis demonstrated that G-CSF or GM-CSF therapy significantly increased the reversal rate from infection, it was not associated with a significant reduction in all cause mortality at 14 days or 28 days, in-hospital mortality or adverse events in patients with sepsis.